Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Infosys - Near-term margins will likely come under pressure - ICICI Securities

Posted On: 2021-01-14 06:22:53 (Time Zone: Arizona, USA)


While peers are still on a recovery mode, Infosys continued its growth streak in Dec-20 (+6.6% YoY, CC, vs +0.4% for TCS and -2% for Wipro) aided by Vanguard deal. However, while peers delivered sequential margin expansion leveraging on offshore shift, the deal ramp-up costs limited such scope for Infosys. Momentum in large deal signings (~US$7bn, includes captive takeovers) continued to be robust. Accordingly, despite a taller revenue base in FY21E, Infosys still anticipates double-digit revenue growth in FY22. (1) Ramp-up of multiple large deals (possibly with some pass-through), (2) FY21E exit margins, and (3) planned utilisation reduction hint at ~230bps YoY EBIT margin contraction (to 22%) in FY22E (I-Sec est). As we rebase our exchange rate assumptions and adjust our estimates to factor-in the large deal impact, our EPS over FY22-FY23E witnesses 5%-9% downgrade. Despite the near-term margin headwinds, we continue to remain positive as Infosys is one of the few names currently operating at stronger business momentum (than pre-Covid). Accordingly, the sharp multiple rerating does not concern us as much as it does in case of other stocks (e.g. Wipro).

- Largely in-line revenues and margins. Revenue growth of 5.3% (QoQ, CC) was ~200bps ahead of our expectations. It is key to note this comes despite the relatively taller revenue base of the company over H1FY21. This strength in revenues was led by residual ramp-up of Vanguard deal. Most segments are running at revenue run rates significantly higher than pre-Covid levels (e.g. FS, Hi-Tech, Life Sciences, North America etc.). Even segments that are not yet at a higher run-rate (e.g. manufacturing) have reported strong QoQ improvement in Dec-20.

Sequentially, EBIT margins remained largely stable. Better operating parameters, e.g. utilisation and onsite-offshore mix, provided 100bps tailwind to margins. However, this was largely negated by transition / rebadging costs (-50bps impact) for the recently won deals, costs due to employee promotions / compensation corrections (-20bps impact) and higher subcon / miscellaneous expenses (-50 bps impact).

- Strong deal win momentum; Upgrade in FY21 revenue / margin guidance. Momentum in large deal signings (~US$7bn, includes captive takeovers) continued to be robust. 73% of this is indicated to be net new. Revised FY21 revenue growth guidance (4.5%-5% YoY, CC) is better than our expectation of 3%-4%. Revised EBIT margin guidance for FY21 is in line with our expectations (24%-24.5%). As large deals ramp up from Q2FY22 onwards, management is confident of achieving double-digit revenue growth in FY22 despite a relative taller base in FY21.

- Near-term margins may come under pressure; nevertheless, maintain BUY. As we rebase our exchange rate assumptions and adjust our estimates to factor-in large deal impact, our EPS over FY22E-FY23E witnesses 5%-9% downgrade. Despite the near-term margin headwinds, we continue to remain positive as Infosys is one of the few companies currently operating at a stronger business momentum (vs pre-Covid). Accordingly, the sharp multiple rerating does not concern us as much as it does in the case of other stocks (e.g. Wipro).

Shares of INFOSYS LTD. was last trading in BSE at Rs.1370.6 as compared to the previous close of Rs. 1387.7. The total number of shares traded during the day was 2734302 in over 62933 trades.

The stock hit an intraday high of Rs. 1384.5 and intraday low of 1318.05. The net turnover during the day was Rs. 3730981293.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd

Company Update - Narayana Hrudayalaya - ICICI Direct

Ambuja Cements - Market share sustenance key for rerating - ICICI Securities

ADD on Astral Poly Technik - An 'astr'onomical growth story - HDFC Securities

FMCG Sector Update Report - Divergence narrows; refocus on core - HDFC Securities

Maintain REDUCE on Jubilant FoodWorks - More legs for growth; reflecting confidence on core - HDFC Securities

Torrent Power - Growth acceleration - ICICI Securities

Mahindra CIE Automotive - CY20 performance closes on a strong note - ICICI Securities

Q3FY21 Company Update - V-Guard Industries - ICICI Direct

Quant Pick - Indus Towers - ICICI Direct

Q4CY20 Result Update - Ambuja Cement - ICICI Direct

Q3FY21 Company Update - Nesco Ltd - ICICI Direct

Maintain BUY on Ambuja Cements - Healthy quarter; multiple triggers ahead - HDFC Securities

Heranba Industries Ltd. - IPO - Sound Financials & Promising Outlook Augur Well

India Equity Strategy Report - Quarterly flipbook: Q3 - upgrades galore! - HDFC Securities

Earnings Wrap Q3FY21: Encouraging quarter, broad based recovery under way!

Shilpa Medicare - USFDA import alert at Jadcherla unit - ICICI Securities

Q3FY21 Company Update - Indian Bank - ICICI Direct

Quant Pick - Torrent Power - ICICI Direct

GE T&D India - Strong cashflow - ICICI Securities

Q3FY21 Result Update - Graphite India - ICICI Direct

Q4CY2020 Result Update - Varun Beverages - ICICI Direct

Q3FY21 Company Update - NBCC Ltd - ICICI Direct

Quant Pick - United Breweries - ICICI Direct

Q4CY2020 Result Update - Nestlé India - ICICI Direct

Q3FY21 Result Update - Time Technoplast - ICICI Direct

Healthy Business Performance Puts ITC Stock Recovery on Track

Gold - Feb 17, 2021 - Reliance Securities

Maintain REDUCE on Nestle India - Steady revenue show; employee cost dents margins - HDFC Securities

Varun Beverages - Q4 CY20 Result and Concall Update - YES Securities

Nestle India - Q4 CY20 Result Update - YES Securities

Reiterate BUY on JMC Projects - Some hits, some misses - HDFC Securities

Varun Beverages - Strong volumes; higher margins - ICICI Securities

Computer Age Management Services - Play on industry AUM growth - ICICI Securities

Nestle India - Just a tad underwhelming (given the high benchmarks expected from Nestle India) - ICICI Securities

NHPC - Earnings robust; projects on track - ICICI Securities

Maintain BUY on ITD Cementation - Gradual recovery shaping up - HDFC Securities

Techno Electric & Engineering - Strong margins, healthy growth outlook - ICICI Securities

Time Technoplast - Outlook upbeat; execution remains key - ICICI Securities



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020